
    
      Patients were randomized to receive either low-dose hydrocortisone or matching
      placebo.Severity of coagulopathy was estimated using ISTH DIC score. We determined the
      complications and mortality in two groups, and analyzed the relationship between
      hydrocortisone and coagulopathy.
    
  